Literature DB >> 7772481

Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study.

G Sais1, A Jucglà, J Peyrí.   

Abstract

To evaluate the prevalence of dermatophyte onychomycosis in Spain, a cross-sectional study was conducted between 1992 and 1993. A total of 10,007 subjects over the age of 15 years were interviewed (using the computer-assisted telephone interview system), completed a directed questionnaire, and reviewed a series of photographs of diverse nail disorders. The period prevalence of onychomycosis was 2.6% and the point prevalence 1.7%. The prevalence of onychomycosis was higher in women (1.8%) than in men (0.8%). Age group distribution showed a higher onychomycosis prevalence (1.2%) in the oldest age group (> 55 years). With regard to localization, the prevalence of toenail onychomycosis was higher than that of fingernail onychomycosis and of concurrent infection in both sites. The results of this study suggest that 802,893 inhabitants of Spain have, or have previously suffered from dermatophyte onychomycosis. Only 38.6% have sought medical advice, and only 14% of those who did so consulted a dermatologist.

Entities:  

Mesh:

Year:  1995        PMID: 7772481     DOI: 10.1111/j.1365-2133.1995.tb00722.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  21 in total

Review 1.  Onychomycosis in the elderly.

Authors:  A K Gupta
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 2.  Onychomycosis. Going for cure.

Authors:  A K Gupta; N H Shear
Journal:  Can Fam Physician       Date:  1997-02       Impact factor: 3.275

3.  In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.

Authors:  M Ghannoum; N Isham; L Long
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

4.  Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.

Authors:  E G Evans; B Sigurgeirsson
Journal:  BMJ       Date:  1999-04-17

Review 5.  Allergy and dermatophytes.

Authors:  Judith A Woodfolk
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Causative Agents of Onychomycosis: A 7-Year Study.

Authors:  Mostafa Chadeganipour; Rasoul Mohammadi
Journal:  J Clin Lab Anal       Date:  2016-04-13       Impact factor: 2.352

7.  Onychomycosis in Rome, Italy.

Authors:  R Mercantini; R Marsella; D Moretto
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

8.  A prospective epidemiologic survey on the prevalence of onychomycosis and dermatophytosis in male boarding school residents.

Authors:  Zulal Erbagci; Almila Tuncel; Yasemin Zer; Iclal Balci
Journal:  Mycopathologia       Date:  2005-04       Impact factor: 2.574

Review 9.  New Antifungal Agents and New Formulations Against Dermatophytes.

Authors:  Aditya K Gupta; Kelly A Foley; Sarah G Versteeg
Journal:  Mycopathologia       Date:  2016-08-08       Impact factor: 2.574

10.  Clinico-mycological profile of dermatophytosis in a reference centre for leprosy and dermatological diseases in Addis Ababa.

Authors:  Y Woldeamanuel; R Leekassa; E Chryssanthou; Y Mengistu; B Petrini
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.